Select therapeutic use:
Indications for Carbinoxamine Maleate Oral Solution:
Allergic (seasonal and perennial) and vasomotor rhinitis, conjunctivitis, urticaria, angioedema, reactions to blood. Adjunct in anaphylaxis. Dermatographism.
4–8mg 3–4 times daily.
<2yrs: contraindicated. 2–5yrs: 0.2–0.4mg/kg/day in 3–4 divided doses. 6–11yrs: 2–4mg 3–4 times daily.
Children <2yrs old. Concomitant MAOIs. Nursing mothers.
Not for treating lower respiratory tract symptoms, including asthma. Narrow angle glaucoma. Peptic ulcer. GI or GU obstruction. Increased intraocular pressure. Hyperthyroidism. Cardiovascular disease. Hypertension. Elderly. Pregnancy (Cat.C).
CNS depression potentiated by alcohol (avoid), other CNS depressants. MAOIs potentiate anticholinergic effects.
Sedation, sleepiness, dizziness, disturbed coordination, GI upset, thickening of bronchial secretions, anticholinergic effects, excitability in children.
Formerly known under the brand name Arbinoxa.